There is a common misconception that “bio-based” means “compostable” or “weak.” In the high-stakes world of biopharmaceutical manufacturing, that couldn’t be further from the truth.
As we scale up single-use technologies (SUT) in 2026, understanding the origins and particularities of these materials is a compliance and sustainability imperative.
As we move through 2026, the biopharma industry is hitting a major sustainability milestone. For years, the move to Single-Use Technology (SUT) was criticized for its plastic waste. Today, one step towards solving that paradox that has been presented is Bio-based Polymers.
I love the smell of a fresh Gantt chart in the morning. It’s the only time the project is actually on schedule.
Let’s be honest, managing projects for bioprocessing facilities can feel like herding cats made of critical deadlines, regulatory demands, and a budget that’s always trying to escape.
But fear not, fellow project managers! We’ve got a secret weapon that turns chaos into controlled brilliance (most of the time): Risk-Based Project Management.
You know that feeling when you’ve just completed a massive project, validation is complete, and you’re ready to ship product? That sweet relief is immediately followed by the cold dread of realizing the FDA Pre-Approval Inspection (PAI) is looming…
In aseptic manufacturing, the PAI isn’t just an inspection -it’s the regulatory World Series, the Aseptic Olympics- success demands a flawless routine without dropping any SOPs. The medal is market access; the judge is the FDA.
The transition to the revised EU GMP Annex 1 (2022) demands a shift from simply building a clean space to engineering a comprehensive Contamination Control Strategy (CCS). Validation issues are often rooted in the design phase, where planning assumptions misalign with operational reality.
If your facility design does not thoroughly address risks associated with operator interventions or material and equipment transfer to sterile areas, you are potentially compromising your sterility assurance.
Copyright (c) 2025, GPharma Solutions Ltd; all rights reserved.
Template by Bootstrapious. Ported to Hugo by DevCows.
